본문바로가기
Language
Q
U
I
C
K

ESG

SK bioscience is committed to establishing a corporate culture
and system for sustainable product development.

Corporate Governance Structure

Differences from best practices

This table summarizes the differences to the best practices as discovered from the assessment.

기업지배구조평가 모범규준 - 구분, 채택여부, 비고 정보제공
Item Adoption Remarks
Enactment of Corporate Governance Charter O Enactment of Corporate Governance Charter on Mar. 31, 2021
Enactment of the Code of Ethics: O Enactment of the Code of Ethics on Jul. 1, 2018
O Enactment of the Code of Ethics Practice Guidelines on Jul. 1, 2018 and then first revision released on Nov. 23, 2020
Introduction of the written voting system X -
Recruitment of BOD members O 67% recruited (4 out of 6) with the majority of outside directors appointed
Regular BOD meetings O Operates under the principle of monthly meetings (Total of 8 meetings in 2020, 16 meetings in 2021)
Prior information on directors for BOD meetings O Disseminated with explanation on agenda 5 days before the meeting
Operational regulations for BOD O Enacted on Dec. 11, 2018, 1st revision on Oct. 29, 2020
Independence of outside directors O Supported by the Outside Director Candidate Recommendation Committee
Internal Expert Committees of the BOD O Audit Committee
Internal Transactions Committee
Outside Director Candidate Recommendation Committee
Personnel Committee
ESG Committee
Insurance for damages for directors at the company costs O Liability insurance purchased for executives (renewed annually)
Exclusive meetings for outside directors O -
Introduction of concentrated voting system X -
Composition of the Audit Committee (all outside directors) O 3 outside directors (including financial experts)
Audit Committee meetings O Total 10 meetings held since the establishment in October 2020
Independence of external auditors O
Accuracy certification of business reports, etc. O Certified by the CEO and responsible executives
Separation of the chairperson of BOD and the CEO X -
Appointment of senior outside director X -
Evaluation of BOD activities O Subject to evaluation from 2021

ESG assessment

Subject to evaluation from 2022